Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma

Clinical trial NCT04595994 · UNKNOWN

Trial details

NCT number: NCT04595994
Sponsor: Grupo Espanol de Investigacion en Sarcomas
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma,Soft Tissue

Start date: 2020-09-02
Primary completion: 2025-11-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.